Embryo implantation involves the initial interaction of the external surface of the trophectoderm of the blastocyst and the apical cell surface of uterine epithelial cells (UEC). A number of studies indicate that heparan sulfate (HS) proteoglycans expressed on embryonic cell surfaces participate in early stages of embryo attachment to UEC in both rodent and human model systems. HS, and the related molecule, heparin (Hp), are structurally diverse polysaccharides that appear to play important roles in normal and malignant cell function, including mediation of cell adhesion and modulation of thrombin activity through their action as a required cofactor for anti-thrombin-3. A prediction from these studies is that UEC surfaces display corresponding HS/Hp binding sites. This prediction has been borne out by the identification of such sites on the surfaces of primary cultures of mouse UEC and human UEC lines. Ultimately, these studies have lead to the identification of a novel, cell surface heparin sulfate/heparin interacting protein (HIP) from human UEC, and other epithelial cells and cell lines. Furthermore, a 17 amino acid synthetic peptide (HIP-peptide-1) of this protein is sufficient to support specific, high affinity binding of Hp/HS in vitro as well as cell adhesion of a variety of human and non-human HS-expressing cell lines. Moreover, HIP and HIP-peptide-1 recognize the subset of Hp that binds to anti-thrombin-3 with highest affinity. As a result, HIP competes with anti-thrombin-3 for Hp binding and effectively activates thrombin and related proteases. Consequently, HIP may directly promote HS-dependent cell adhesion and indirectly promote thrombin-stimulated proteolytic cascades, induction of additional cell adhesion systems and cell proliferation. HIP is expressed in an appropriate locale to participate in HS-dependent processes of UEC. In the proposed studies, the investigators will use site-directed mutagenesis and biochemical approaches to define the structural requirements for HIP activity. Definition of these structural requirements will provide peptide targets and reagents to selectively perturb associated activities. These reagents then may be used to interrupt or enhance these activities, not only in the context of implantation, but in a variety of other contexts in which HS or thrombin is known to play a critical role, e.g., blot clotting. In addition, they will specifically examine HIP expression and function in murine embryo attachment in vitro and in vivo.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD025235-13
Application #
6181579
Study Section
Reproductive Endocrinology Study Section (REN)
Program Officer
Yoshinaga, Koji
Project Start
1988-12-01
Project End
2001-12-31
Budget Start
2000-07-01
Budget End
2001-12-31
Support Year
13
Fiscal Year
2000
Total Cost
$198,120
Indirect Cost
Name
University of Delaware
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
059007500
City
Newark
State
DE
Country
United States
Zip Code
19716
Oristian, Daniel S; Sloofman, Laura G; Zhou, Xiaozhou et al. (2009) Ribosomal protein L29/HIP deficiency delays osteogenesis and increases fragility of adult bone in mice. J Orthop Res 27:28-35
D'Souza, Sonia S; Fazleabas, Asgerally T; Banerjee, Prajna et al. (2008) Decidual heparanase activity is increased during pregnancy in the baboon (Papio anubis) and in in vitro decidualization of human stromal cells. Biol Reprod 78:316-23
Farach-Carson, Mary C; Carson, Daniel D (2007) Perlecan--a multifunctional extracellular proteoglycan scaffold. Glycobiology 17:897-905
D'Souza, Sonia S; Daikoku, Takiko; Farach-Carson, Mary C et al. (2007) Heparanase expression and function during early pregnancy in mice. Biol Reprod 77:433-41
Kirn-Safran, Catherine B; Oristian, Daniel S; Focht, Richard J et al. (2007) Global growth deficiencies in mice lacking the ribosomal protein HIP/RPL29. Dev Dyn 236:447-60
Liu, Jian-Jun; Zhang, Jinqiu; Ramanan, Sriram et al. (2004) Heparin/heparan sulfate interacting protein plays a role in apoptosis induced by anticancer drugs. Carcinogenesis 25:873-9
Reiland, Jane; Sanderson, Ralph D; Waguespack, Marian et al. (2004) Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion. J Biol Chem 279:8047-55
Miller, Stephanie A; Brown, Anissa J; Farach-Carson, Mary C et al. (2003) HIP/RPL29 down-regulation accompanies terminal chondrocyte differentiation. Differentiation 71:322-36
Ta, T-V; Baraniak, D; Julian, J et al. (2002) Heparan sulfate interacting protein (HIP/L29) negatively regulates growth responses to basic fibroblast growth factor in gingival fibroblasts. J Dent Res 81:247-52
Carson, Daniel D (2002) The glycobiology of implantation. Front Biosci 7:d1535-44

Showing the most recent 10 out of 40 publications